In vitro Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia

Thrombocytopenia is common among critically ill sepsis patients, while they also hold an increased risk for thromboembolic events. Thus, the choice of anticoagulant prophylaxis for this patient population is challenging. We investigated the in vitro effect of low-molecular-weight heparin (dalteparin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nygaard, Søren, Hvas, Christine L., Hvas, Anne-Mette, Adelborg, Kasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886503/
https://www.ncbi.nlm.nih.gov/pubmed/36751302
http://dx.doi.org/10.1055/a-2000-6576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886503/
https://www.ncbi.nlm.nih.gov/pubmed/36751302
http://dx.doi.org/10.1055/a-2000-6576

Ejemplares similares